# US 2008/0188556 A1 · Water-Soluble Prodrugs of Florfenicol and its Analogs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0188556 A1
- Document ID: US20080188556A1
- Status: Published application
- Kind: A1
- Application number: 11/953,962
- Filed: 2007-12-11
- Published: 2008-08-07
- Earliest claimed: 2006-12-13
- Assignees: Intervet Inc.
- Inventors: Tomasz W. Glinka; Jason Z. Zhang
- Web page: https://patentgrep.com/patent/US20080188556A1

## CPC

- C07D 233/60: with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
- A61P 31/04: Antibacterial agents
- C07C 317/32: with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07D 233/54: having two double bonds between ring members or between ring members and non-ring members
- C07K 5/06191: {containing heteroatoms different from O, S, or N}
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention discloses certain novel prodrugs of florfenicol and/or of florfenicol analogs, including prodrugs of salts pharmaceutically acceptable salts of florfenicol and its analogs, including nitrogen-containing esters of the secondary alcohol group of florfenicol and of its analogs, and pharmaceutically acceptable salts thereof, compositions containing them, and methods of administering them to subjects. In particular embodiments the prodrugs are sufficiently water-soluble to serve the functions needed of a water-soluble prodrug of florfenicol or of a water-soluble prodrug of a florfenicol analog. A certain subclass of the compounds also possesses the hydrolytic stability needed to maintain the prodrug in solution in the subject's system until appropriate conditions exist when the prodrug can hydrolyze, releasing florfenicol or the florfenicol analog in question.

## Claims

### Claim 1

A compound having the Formula (I)
in which:
R is selected from the group consisting of
A is oxygen and a is zero or 1;
L is (a) CH2 and l is an integer from 1 to 6; (b) CHR1 where R1 is an amino acid side chain and l is 1; or (c) CHR1NHC(O)C(NH2)R2 where R1 and R2 are amino acid side chains and l is 1;
M is (a) oxygen or sulfur and m is zero or one; (b) CH2 and m is zero or an integer from 1 to 4; or (e) NH and m is 1;
X is (a) CH1 and x is zero or an integer from 1 to 4; or (b) C(O) and x is 1; and Y is (a) NH2; (b) NHRx where Rx is methyl, ethyl, n-propyl or isopropyl; (c) NRyRz where Ry and Rz are independently hydrogen, methyl, ethyl, n-propyl or isopropyl, or Ry and Rz taken together form a C2-C5 alkylene chain or a C2-C4 alkylene chain further including a nitrogen or oxygen heteroatom in said chain; (d) C(═NH)NH2; (e) N+R4R5R6 where R4, R5 and R6 are independently hydrogen, methyl or ethyl, or R4 and R5 taken together form a C2-C5 alkylene chain, or a C2-C4 alkylene chain further including a nitrogen or oxygen heteroatom in said chain; (f) pyridinium; (g) N-methyl or N-ethyl pyridinium; (h) N′-3-methyl-N-1-imidazolium; (i) a phenyl group substituted by a group having the formula NR4R5 or N+R4R5R6 where R4, R5 and R6 are as defined above; or (j) NH—CR3(═NH) where R3 is hydrogen, methyl or amino;
and R7 is selected from the group consisting of dichloromethyl, difluoromethyl, trifluoromethyl, cyanomethyl, azidomethyl, and aminomethyl;
provided that the group AaL1MmXxY is other than an alpha-N-unfunctionalized glycine, ornithine or lysine residue;
and pharmaceutically acceptable salts thereof.

### Claim 2

A compound having the Formula (II):
in which:
A is oxygen and a is zero or 1;
L is (a) CH2 and l is an integer from 1 to 5 or (b) CHR1 where R1 is an amino acid side chain and l is 1; or (c) CHR1NHC(O)CH(NH2)R2 where R2 is an amino acid side chain and l is 1;
M is (a) oxygen and m is zero or one; (b) CH2 and m is zero or an integer from 1 to 4;
or (c) NH and m is 1;
X is (a) CH2 and x is zero or an integer from 1 to 4; or (b) C(O) and x is 1; and
Y is (a) NH2; (b) NHRx, where Rx is methyl, ethyl, n-propyl or isopropyl; (c) NRyRz where Ry and Rz are independently hydrogen, methyl, ethyl, n-propyl or isopropyl;
(d) C(═NH)NH2; (e) N+R4R5R6 where R4, R5 and R6 are independently hydrogen, methyl or ethyl; (f) N-pyridinium; (g) N′-3-methyl-N-1-imidazolium; or (h) NH—CR3(═NH) where R3 is hydrogen, methyl or amino;
and R7 is selected from the group consisting of dichloromethyl, difluoromethyl, trifluoromethyl cyanomethyl, azidomethyl, and aminomethyl;
provided that the sum of a+l+m+x is from 2 to 6 and preferably from 3 to 6;
provided that if a is 1, then M is (CH2)m;
and provided that the group AaLlMmXxY is other than an alpha-N-unfunctionalized glycine, ornithine or lysine residue;
and pharmaceutically acceptable salts thereof.

### Claim 3 (depends on 2)

A compound according to claim 2 in which Y is a positively charged moiety separated from the carbonyl group by at least two atoms in the chain.

### Claim 4 (depends on 2)

A compound according to claim 2 in which a is zero.

### Claim 5 (depends on 1)

A compound according to claim 1 in which a is 1.

### Claim 6 (depends on 2)

A compound according to claim 2 in which L is CH2 and l is an integer from 1 to 5.

### Claim 7 (depends on 2)

A compound according to claim 2 in which M is CH2 and m is an integer from 1 to 4.

### Claim 8 (depends on 2)

A compound according to claim 2 in which X is CH1) and x is an integer from 1 to 4.

### Claim 9 (depends on 2)

A compound according to claim 2 in which Y is NR4R5R6+.

### Claim 10 (depends on 2)

A compound according to claim 2 in which R7 is dichloromethyl.

### Claim 11 (depends on 1)

A pharmaceutical composition comprising a therapeutically effective amount of a compound or salt according to claim 1 and a pharmaceutically acceptable diluent or carrier.

### Claim 12 (depends on 1, 10)

A composition according to claim 10 comprising a therapeutically effective amount of a compound or salt according to claim 1.

### Claim 13 (depends on 2, 10)

A composition according to claim 10 comprising a therapeutically effective amount of a compound or salt according to claim 2.

### Claim 14 (depends on 8)

A composition according to claim 8 further comprising an effective amount of one or more additional medicinal agents.

### Claim 15 (depends on 14)

A composition according to claim 14 in which the one or more additional medicinal agents are selected from microbiocides, anthelmintics, ecto- and endoparasticides, anti-fluke agents, anti-inflammatories, anti-infectives, hormones, dermatological preparations, including antiseptics and disinfectants, and immunobiologicals including vaccines and antisera.

### Claim 16 (depends on 1)

A method of treating or preventing a disease or disorder in a subject comprising administering to said subject a therapeutically effective amount of a compound according to claim 1.

### Claim 17 (depends on 2)

A method of treating or preventing a disease or disorder in a subject comprising administering to said subject a therapeutically effective amount of a compound according to claim 2.

### Claim 18 (depends on 10)

A method of treating or preventing a disease or disorder in a subject comprising administering to said subject a therapeutically effective amount of a composition according to claim 10.

### Claim 19 (depends on 13)

A method of treating or preventing a disease or disorder in a subject comprising administering to said subject a therapeutically effective amount of a composition according to claim 13.

### Claim 20 (depends on 14)

A method of treating or preventing a disease or disorder in a subject comprising administering to said subject a therapeutically effective amount of a composition according to claim 14.

### Claim 21 (depends on 15)

A method of treating or preventing a disease or disorder in a subject comprising administering to said subject a therapeutically effective amount of a composition according to claim 15.
